STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,489,000 | -31.3% | 2,200,172 | 0.0% | 0.00% | – |
| Q2 2021 | $6,534,000 | +2.3% | 2,200,172 | -4.9% | 0.00% | – |
| Q1 2021 | $6,387,000 | +28.0% | 2,314,215 | +12.7% | 0.00% | – |
| Q4 2020 | $4,990,000 | +26.2% | 2,053,576 | +9.0% | 0.00% | – |
| Q3 2020 | $3,955,000 | -44.1% | 1,883,191 | +0.6% | 0.00% | – |
| Q2 2020 | $7,076,000 | +107.2% | 1,871,969 | +3.6% | 0.00% | – |
| Q1 2020 | $3,415,000 | +12.6% | 1,807,010 | +24.5% | 0.00% | – |
| Q4 2019 | $3,033,000 | +176.0% | 1,451,134 | +215.6% | 0.00% | – |
| Q3 2019 | $1,099,000 | +327.6% | 459,861 | +460.0% | 0.00% | – |
| Q2 2019 | $257,000 | -67.7% | 82,114 | -8.7% | 0.00% | – |
| Q1 2018 | $796,000 | +43.4% | 89,978 | +17.5% | 0.00% | – |
| Q4 2017 | $555,000 | +22.2% | 76,584 | +16.5% | 0.00% | – |
| Q3 2017 | $454,000 | -4.2% | 65,747 | -1.0% | 0.00% | – |
| Q2 2017 | $474,000 | – | 66,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |